Metaphore Biotechnologies
Abdul Bais Kadli is a Senior Research Associate I at Metaphore Biotechnologies, specializing in antibody discovery and phage display screening automation since June 2022. Previously, Abdul held a similar position at Solid Biosciences, focusing on gene therapy for Duchenne Muscular Dystrophy, where responsibilities included establishing downstream processes for viral vectors, viral quantification, and cell maintenance. Abdul's research background includes a Graduate Research Assistant role at the University of Florida, emphasizing high-throughput profiling of enzymatic activity, alongside quality and nutritional analysis in hydroponic lettuce. Educational qualifications include a Master's degree in Chemical Engineering from the University of Florida and a Bachelor of Engineering from Siddaganga Institute of Technology. Additional experiences comprise internships in quality management systems and industrial training in quality control for various organizations.
This person is not in any offices
Metaphore Biotechnologies
Metaphore Biotechnologies is harnessing the power of biomimicry and machine learning to unlock the transformative therapeutic potential of functional molecular mimics. The company’s MIMiC™ platform is a computationally driven bioplatform designing new therapeutics where function, specificity, and selectivity can be optimized. Metaphore is focused on making previously intractable drug targets accessible and unlocking breakthroughs that outperform today’s drugs for maximum patient impact. Metaphore was founded in 2021 in Flagship Labs, a unit of Flagship Pioneering.